Sickle-Chex Solubility Kit
510(k) K023656
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK023656 | Date30 Dec 2002 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GHM
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.7825
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Sickle-Chex Solubility Kit is a qualitative in vitro diagnostic device designed for testing the presence of sickling hemoglobins in human blood or sickle cell control material. Classified under the nomenclature for Test, Sickle Cell (GHM), it is intended for use in hematology laboratories to assess sickle cell traits or disease through solubility testing. The device operates by detecting abnormal hemoglobin variants that cause sickling under specific conditions, aiding in the identification of sickle cell disorders.
This kit is supplied as a manual test system, requiring no additional sterilization as it is intended for single-use per test. It is compatible with various solubility test methods, including Streck’s SICKLEDEX, and includes necessary components such as a solubility test reagent and a whole blood control. Storage conditions are not specified in regulatory data, but typical in vitro diagnostics are maintained at controlled room temperature (2–25°C) away from direct light. The device holds FDA 510(k) clearance (K023656) under the Hematology advisory committee, adhering to regulatory standards for diagnostic accuracy and performance.
Other devices from Streck Laboratories, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the Sickle-Chex Solubility Kit used for?
The Sickle-Chex Solubility Kit is designed for qualitative in vitro testing to detect the presence of sickling hemoglobins in human blood or sickle cell control material. It helps hematology laboratories identify sickle cell traits or disease by assessing abnormal hemoglobin variants that cause sickling under specific conditions. This aids in diagnosing sickle cell disorders through solubility testing.
How is the Sickle-Chex Solubility Kit supplied and used?
The kit is supplied as a manual test system, meaning it requires no additional sterilization and is intended for single-use per test. It includes essential components like a solubility test reagent and a whole blood control, making it ready for immediate use in compatibility with methods such as Streck’s SICKLEDEX.
Is the Sickle-Chex Solubility Kit sterile and reusable?
No, the Sickle-Chex Solubility Kit is not sterile beyond its single-use design—it is intended for one-time use per test and does not require sterilization. It is a manual test system, so reuse is not applicable or recommended.
What storage conditions should be followed for the Sickle-Chex Solubility Kit?
While specific storage conditions are not detailed in regulatory data, typical in vitro diagnostics like this kit are generally stored at controlled room temperature (2–25°C) away from direct light. This ensures stability and maintains the integrity of the test components.
What regulatory clearance does the Sickle-Chex Solubility Kit hold?
The Sickle-Chex Solubility Kit holds FDA 510(k) clearance (K023656) under the Hematology advisory committee. This clearance confirms its substantial equivalence to a predicate device and adherence to regulatory standards for diagnostic accuracy and performance in sickle cell testing.